1-4 of 4
Ed Schuuring, PhD
Close
Sort by
Journal Articles

MicroRNAs Specific for Immune-Privileged Diffuse Large B-Cell Lymphoma.

JanLukas Robertus, MD, Geert Harms, MSc, Tjasso Blokzijl, MSc, Daphne de Jong, MD PhD, Marije Booman, Ir, Stefano Rosati, MD, Ed Schuuring, PhD, Philip M. Kluin, MD PhD, Anke van den Berg, PhD
Journal: Blood
Blood (2007) 110 (11): 1566.
https://doi.org/10.1182/blood.V110.11.1566.1566
Published: 2007
Journal Articles

Differences in the C13orf25 miRNA Cluster in Non-Hodgkin Lymphoma and Normal B-Cell Subtypes.

Jan-Lukas Robertus, MD, Miao Wang, MD, Geert Harms, MSc, Tjasso Blokzijl, MSc, Rikst Nynke Schakel, MSc, Daphne de Jong, MD PhD, Rogier M. Reijmers, MSc, Steven T. Pals, MD PhD, Stefano Rosati, MD, Ed Schuuring, PhD, Philip M. Kluin, MD PhD, Anke van den Berg, PhD
Journal: Blood
Blood (2007) 110 (11): 3586.
https://doi.org/10.1182/blood.V110.11.3586.3586
Published: 2007
Journal Articles

The Grey Zone between Burkitt and Diffuse Large B Cell Lymphomas: Impact of Chromosomal Breakponts at Myc and Other Loci.

Eugenia Haralambieva, Evert-jan Boerma, Gustaaf van Imhoff, MD, Stefano Rosati, MD, Ed Schuuring, PhD, Hans-Konrad Mueller-Hermelink, MD PhD, Philip M. Kluin, MD PhD, German Ott, MD PhD
Journal: Blood
Blood (2004) 104 (11): 2275.
https://doi.org/10.1182/blood.V104.11.2275.2275
Published: 2004
Journal Articles

Altered Replication Timing of IGH Alleles in Burkitt’s Lymphoma Depends on IGH Breakpoint Position.

Jeroen E.J. Guikema, PhD, Conny de Boer, Jules Gadiot, Ed Schuuring, PhD, Philip M. Kluin, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4276.
https://doi.org/10.1182/blood.V104.11.4276.4276
Published: 2004